Weave Bio

Weave Bio is an AI-native software company based in San Francisco, California. It has built a cloud-based platform for the life sciences industry that automates and streamlines regulatory workflows across drug development, from lab to market. The company's technical work spans artificial intelligence and machine learning, cloud software, regulatory automation, eCTD document formatting and templating, and natural language and generative AI authoring tools.

Its product, the Weave Platform, supports the full regulatory content lifecycle: authoring, data organisation, review, publishing, and Health Authority Question (HAQ) response management. The platform provides eCTD-formatted templates alongside AI-powered tools intended to make submissions faster and more accurate.

Weave Bio serves pharmaceutical companies, biotech firms, contract research organisations and regulatory consulting organisations. It has strategic partnerships with Parexel and Takeda, and is backed by US Venture Partners, Character Capital, Innovation Endeavors, Magnetic Ventures and True Ventures. The company was founded by a multidisciplinary team of scientists, engineers and regulatory experts.